FluoroPharma Medical Inc. announced that Dr. Thomas H. Tulip will join the company as President and will be responsible for the company's day-to-day operations, with a focus on global product and business development strategies. Prior to joining FluoroPharma, Dr. Tulip served in leadership roles at Navidea BioPharmaceuticals, Inc. from 2011-2015. He spent more than 25 years in the development and commercialization of radiopharmaceuticals and imaging agents, with a track record of success in R&D, business development, brand and alliance management as well as international business.